Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Abbott Laboratories ha un prezzo obiettivo di consenso di $143 basato sulle valutazioni di 23 analisti. Il massimo è $162, pubblicato da Barclays il ottobre 17, 2025. Il minimo è $120, pubblicato da Jefferies il settembre 26, 2024. Le 3 valutazioni di analisti più recenti sono state pubblicate da BTIG, Barclays e Raymond James il novembre 20, 2025, ottobre 17, 2025 e ottobre 16, 2025. Con un prezzo obiettivo medio di $151 tra BTIG, Barclays e Raymond James, c’è una variazione implicita del 20.22% upside per Abbott Laboratories a partire da queste ultime valutazioni degli analisti.
1calcolato in base alle valutazioni degli analisti
| Get Alert | |||||
|---|---|---|---|---|---|
| Nov 20, 2025 | 15.45% | 145145 | Previous Buy Current Buy | Get Alert | |
| Oct 17, 2025 | 28.98% | 159162 | Previous Overweight Current Overweight | Get Alert | |
| Oct 16, 2025 | 16.24% | 141146 | Previous Outperform Current Outperform | Get Alert | |
| Oct 16, 2025 | 13.06% | 142144 | Previous Outperform Current Outperform | Get Alert | |
| Oct 16, 2025 | 17.04% | 147147 | Previous Outperform Current Outperform | Get Alert | |
| Oct 16, 2025 | 16.24% | 142146 | Previous Overweight Current Overweight | Get Alert | |
| Oct 15, 2025 | 15.45% | 145145 | Previous Buy Current Buy | Get Alert | |
| Oct 10, 2025 | 15.45% | 145 | Previous Initiates Current Buy | Get Alert | |
| Oct 7, 2025 | 14.65% | 140144 | Previous Outperform Current Outperform | Get Alert | |
| Jul 18, 2025 | 23.41% | 155157 | Previous Buy Current Buy | Get Alert | |
| Jul 18, 2025 | 13.06% | 142147 | Previous Overweight Current Overweight | Get Alert | |
| Jul 18, 2025 | 12.26% | 141142 | Previous Outperform Current Outperform | Get Alert | |
| Jul 18, 2025 | 7.48% | 135140 | Previous Neutral Current Neutral | Get Alert | |
| Jul 18, 2025 | 15.45% | 143145 | Previous Hold Current Buy | Get Alert | |
| Jul 18, 2025 | 15.45% | 145148 | Previous Buy Current Buy | Get Alert | |
| Jul 17, 2025 | 11.46% | 140145 | Previous Outperform Current Outperform | Get Alert | |
| Jul 16, 2025 | 11.46% | 130140 | Previous Neutral Current Neutral | Get Alert | |
| Jul 15, 2025 | 17.04% | 145147 | Previous Outperform Current Outperform | Get Alert | |
| Jul 15, 2025 | 9.08% | 127137 | Previous Equal-Weight Current Equal-Weight | Get Alert | |
| Jul 14, 2025 | 17.83% | 145148 | Previous Buy Current Buy | Get Alert | |
| Jul 9, 2025 | 25% | 155157 | Previous Buy Current Buy | Get Alert | |
| Jul 8, 2025 | 15.45% | 140145 | Previous Outperform Current Outperform | Get Alert | |
| Jun 20, 2025 | 13.85% | 137143 | Previous Hold Current Hold | Get Alert | |
| Apr 17, 2025 | 15.45% | 140145 | Previous Buy Current Buy | Get Alert | |
| Apr 17, 2025 | 14.65% | 138144 | Previous Outperform Current Outperform | Get Alert | |
| Apr 17, 2025 | 13.06% | 132142 | Previous Outperform Current Outperform | Get Alert | |
| Apr 17, 2025 | 15.45% | 133145 | Previous Overweight Current Overweight | Get Alert | |
| Apr 17, 2025 | 15.45% | 140145 | Previous Outperform Current Outperform | Get Alert | |
| Apr 17, 2025 | 17.04% | 136147 | Previous Overweight Current Overweight | Get Alert | |
| Apr 17, 2025 | 1.11% | 117127 | Previous Equal-Weight Current Equal-Weight | Get Alert | |
| Apr 17, 2025 | 26.59% | 158159 | Previous Overweight Current Overweight | Get Alert | |
| Apr 17, 2025 | 15.45% | 135145 | Previous Buy Current Buy | Get Alert | |
| Apr 17, 2025 | 9.08% | 135137 | Previous Hold Current Hold | Get Alert | |
| Apr 16, 2025 | 11.46% | 138140 | Previous Outperform Current Outperform | Get Alert | |
| Apr 15, 2025 | 11.46% | 135140 | Previous Outperform Current Outperform | Get Alert | |
| Mar 10, 2025 | 19.43% | 133150 | Previous Buy Current Buy | Get Alert | |
| Mar 4, 2025 | 27.39% | 135160 | Previous Buy Current Buy | Get Alert | |
| Mar 4, 2025 | 22.61% | 138154 | Previous Buy Current Buy | Get Alert | |
| Jan 27, 2025 | 25.8% | 149158 | Previous Overweight Current Overweight | Get Alert | |
| Jan 23, 2025 | 7.48% | 125135 | Previous Hold Current Hold | Get Alert | |
| Jan 23, 2025 | 9.87% | 135138 | Previous Outperform Current Outperform | Get Alert | |
| Jan 23, 2025 | 7.48% | 135135 | Previous Outperform Current Outperform | Get Alert | |
| Jan 23, 2025 | 8.28% | 133136 | Previous Overweight Current Overweight | Get Alert | |
| Jan 23, 2025 | 7.48% | 130135 | Previous Buy Current Buy | Get Alert | |
| Jan 23, 2025 | 17.83% | 146148 | Previous Buy Current Buy | Get Alert | |
| Jan 22, 2025 | 11.46% | 139140 | Previous Buy Current Buy | Get Alert | |
| Jan 21, 2025 | 7.48% | 135135 | Previous Outperform Current Outperform | Get Alert | |
| Jan 8, 2025 | 7.48% | 135138 | Previous Outperform Current Outperform | Get Alert | |
| Jan 2, 2025 | 8.28% | 128136 | Previous Outperform Current Outperform | Get Alert | |
| Dec 20, 2024 | 7.48% | 130135 | Previous Outperform Current Outperform | Get Alert | |
| Nov 5, 2024 | 18.63% | 143149 | Previous Overweight Current Overweight | Get Alert | |
| Oct 17, 2024 | 9.87% | 133138 | Previous Outperform Current Outperform | Get Alert | |
| Oct 17, 2024 | 16.24% | 143146 | Previous Buy Current Buy | Get Alert | |
| Oct 17, 2024 | -0.48% | 120125 | Previous Hold Current Hold | Get Alert | |
| Oct 17, 2024 | 3.5% | 115130 | Previous Neutral Current Neutral | Get Alert | |
| Oct 17, 2024 | 5.89% | 131133 | Previous Overweight Current Overweight | Get Alert | |
| Oct 17, 2024 | -6.85% | 107117 | Previous Equal-Weight Current Equal-Weight | Get Alert | |
| Oct 16, 2024 | 3.5% | 125130 | Previous Buy Current Buy | Get Alert | |
| Oct 16, 2024 | 1.91% | 124128 | Previous Outperform Current Outperform | Get Alert | |
| Oct 16, 2024 | 10.67% | 135139 | Previous Buy Current Buy | Get Alert | |
| Oct 14, 2024 | 2.71% | 122129 | Previous Outperform Current Outperform | Get Alert | |
| Oct 8, 2024 | 3.5% | 125130 | Previous Outperform Current Outperform | Get Alert | |
| Oct 8, 2024 | 3.5% | 130 | Previous Initiates Current Outperform | Get Alert | |
| Oct 1, 2024 | -1.27% | 120124 | Previous Outperform Current Outperform | Get Alert | |
| Sep 26, 2024 | -4.46% | 120120 | Previous Hold Current Hold | Get Alert | |
| Sep 19, 2024 | 4.3% | 131 | Previous Initiates Current Overweight | Get Alert | |
| Aug 27, 2024 | -4.46% | 112120 | Previous Buy Current Buy | Get Alert | |
| Aug 22, 2024 | 1.11% | 119127 | Previous Buy Current Buy | Get Alert | |
| Jul 29, 2024 | 13.85% | 140143 | Previous Overweight Current Overweight | Get Alert | |
| Jul 2, 2024 | -4.46% | 120125 | Previous Outperform Current Outperform | Get Alert | |
| Jun 4, 2024 | -0.48% | 125125 | Previous Outperform Current Outperform | Get Alert | |
| May 30, 2024 | -3.66% | 121 | Previous Initiates Current Buy | Get Alert | |
| May 22, 2024 | -5.25% | 119128 | Previous Buy Current Buy | Get Alert | |
| Apr 22, 2024 | 11.46% | 140141 | Previous Overweight Current Overweight | Get Alert | |
| Apr 18, 2024 | -0.48% | 125128 | Previous Outperform Current Outperform | Get Alert | |
| Apr 4, 2024 | -0.48% | 120125 | Previous Outperform Current Outperform | Get Alert | |
| Apr 3, 2024 | 1.91% | 126128 | Previous Buy Current Buy | Get Alert | |
| Feb 14, 2024 | 1.91% | 128128 | Previous Outperform Current Outperform | Get Alert | |
| Jan 26, 2024 | 12.26% | 133141 | Previous Overweight Current Overweight | Get Alert | |
| Jan 25, 2024 | 5.89% | 131133 | Previous Overweight Current Overweight | Get Alert | |
| Jan 25, 2024 | 1.91% | 128128 | Previous Outperform Current Outperform | Get Alert | |
| Jan 25, 2024 | 0.32% | 123126 | Previous Buy Current Buy | Get Alert | |
| Jan 25, 2024 | 1.11% | 124127 | Previous Outperform Current Outperform | Get Alert | |
| Jan 16, 2024 | 4.3% | 121131 | Previous Overweight Current Overweight | Get Alert | |
| Jan 11, 2024 | 1.91% | 119128 | Previous Outperform Current Outperform | Get Alert | |
| Jan 3, 2024 | -1.27% | 110124 | Previous Outperform Current Outperform | Get Alert | |
| Dec 13, 2023 | -3.66% | 116121 | Previous Overweight Current Overweight | Get Alert | |
| Dec 11, 2023 | -2.07% | 122123 | Previous Buy Current Buy | Get Alert | |
| Oct 19, 2023 | 5.89% | 132133 | Previous Overweight Current Overweight | Get Alert | |
| Oct 19, 2023 | -14.81% | 107112 | Previous Equal-Weight Current Equal-Weight | Get Alert | |
| Oct 19, 2023 | -7.64% | 116136 | Previous Overweight Current Overweight | Get Alert | |
| Oct 19, 2023 | -12.42% | 110123 | Previous Outperform Current Outperform | Get Alert | |
| Oct 2, 2023 | -10.83% | 112120 | Previous Hold Current Hold | Get Alert | |
| Oct 2, 2023 | -2.87% | 122130 | Previous Buy Current Buy | Get Alert | |
| Jul 24, 2023 | 5.1% | 127132 | Previous Overweight Current Overweight | Get Alert | |
| Jul 21, 2023 | -10.83% | 112112 | Previous Equal-Weight Current Equal-Weight | Get Alert | |
| Jul 21, 2023 | -8.44% | 110115 | Previous Neutral Current Neutral | Get Alert | |
| Jul 21, 2023 | — | — | Previous Underperform Current Peer Perform | Get Alert | |
| May 30, 2023 | -10.83% | 112 | Previous Current Equal-Weight | Get Alert | |
| Apr 20, 2023 | 3.5% | 117130 | Previous Current Buy | Get Alert |
L'ultimo obiettivo di prezzo per Abbott Laboratories (NYSE:ABT) è stato riportato da {{analyst} in data {{date}}. La società di analisi ha fissato un obiettivo di prezzo per $145.00 prevedendo che ABT raggiunga rise entro 12 mesi (un possibile 15.45% upside).
L'ultima valutazione degli analisti per Abbott Laboratories (NYSE:ABT) è stato fornita da BTIG e Abbott Laboratories ribadito il suo rating buy.
L'ultima revisione al rialzo di Abbott Laboratories è avvenuta il luglio 18, 2025, quando Jefferies ha alzato il suo obiettivo di prezzo a $145. In precedenza Jefferies aveva a hold per Abbott Laboratories.
Non esiste una revisione finale al ribasso per Abbott Laboratories.
Gli analisti giungono alle valutazioni dei titoli dopo aver fatto ricerche approfondite, che comprendono l'esame dei bilanci pubblici, i colloqui con i dirigenti e i clienti di Abbott Laboratories e l'ascolto delle comunicazioni degli utili. La maggior parte degli analisti svolge questa attività ogni tre mesi, quindi dovresti ricevere 4 valutazioni all'anno per azienda e per società. L'ultima valutazione di Abbott Laboratories è stata depositata il novembre 20, 2025, quindi dovresti aspettarti che la prossima valutazione sia disponibile intorno a novembre 20, 2026.
Sebbene le valutazioni siano soggettive e possano cambiare, l'ultima valutazione di Abbott Laboratories (ABT) è stata una ribadito con un obiettivo di prezzo di $145.00 a $145.00. Il prezzo attuale a cui Abbott Laboratories (ABT) è scambiato è $125.60, che è out of del range previsto dall'analista.
Sfoglia valutazioni degli analisti e obiettivi di prezzo su tutte le azioni.